In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis

Human Reproduction Update

Volumn 13, Issue 4, 2007, Pages 331-342

  Laschke, Matthias W ^a   Menger, Michael D ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Dorsal skinfold chamber; Endometriosis; Peritoneal fluid; Rodent models

Indexed keywords

ADENOVIRUS VECTOR; ADIPONECTIN; ANDROGEN; ANGINEX; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANGIOGENIN; ANGIOSTATIN; AROMATASE INHIBITOR; CAPLOSTATIN; CYCLOOXYGENASE 2 INHIBITOR; ENDOSTATIN; ERYTHROPOIETIN; FUMAGILLOL CHLOROACETYLCARBAMATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GONADORELIN DERIVATIVE; GROWTH FACTOR; IMMUNOLOGIC FACTOR; INTERLEUKIN 15; INTERLEUKIN 8; LEVONORGESTREL; MACROPHAGE MIGRATION INHIBITION FACTOR; ORAL CONTRACEPTIVE AGENT; PROMEGESTONE; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; CELL CULTURE; CHORIOALLANTOIS; DISEASE COURSE; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC ANALYSIS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL FLUID; PRIMATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW; RODENT; SCID MOUSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CHORIOALLANTOIC MEMBRANE; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PRIMATES; RODENTIA;

EID: 34447339376     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmm006     Document Type: Review

References (115)

1. Absenger Y, Hess-Stumpp H, Kreft B et al. Cy61, a deregulated gene in endometriosis. Mol Hum Reprod 2004;10:399-407.
2. Akoum A, Lawson C, McColl S et al. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod 2001;7 859-66.
3. Arici A, Matalliotakis I, Goumenou A et al. Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion. Hum Reprod 2003;18:429-32.
4. Arici A, Tazuke SI, Attar E et al. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996;2:40-5.
5. Awwad JT, Sayegh RA, Tao XJ et al. The SCID mouse: An experimental model for endometriosis. Hum Reprod 1999;14:3107-11.
6. Barcz E. Rozewska ES, Kaminski P et al. Angiogenic activity and IL-8 concentrations in peritoneal fluid and sera in endometriosis. Int J Gynaecol Obstet 2002;79:229-35.
7. Becker CM, Sampson DA, Rupnick MA et al. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril 2005;84 (suppl. 2):1144-55.
8. Becker CM, Sampson DA, Short SM et al. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. Fertil Steril 2006a;85:71-7.
9. Becker CM, Wright RD, Satchi-Fainaro R et al. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am J Pathol 2006b;168:2074-84.
10. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125:1591-8.
11. Bourlev V, Volkov N, Pavlovitch S et al. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 2006;132:501-19.
12. Bruner KL, Matrisian LM, Rodgers, WH et al. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997;99:2851-7.
13. Buerkle MA, Lehrer S, Sohn HY et al. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo. Circulation 2004;110:2053-9.
14. Cardon SZ, Oestermeyer CF, Bloch EH. Effect of oxygen on cyclic red blood cell flow in unanesthetized mammalian striated muscle as determined by microscopy. Microvasc Res 1970;2:67-76.
15. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95.
16. Chung HW, Wen Y, Choi EA et al. Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis. Mol Hum Reprod 2002;8:350-55.
17. Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci 2002;955:11-22.
18. Dabrosin C, Gyorffy S, Margetts P et al. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. Am J Pathol 2002;161:909-18.
19. Defrère S, Van Langendonckt A, Gonzalez Ramos R et al. Quantification of endometriotic lesions in a murine model by fluorimetric and morphometric analyses. Hum Reprod 2006;21 810-17.
20. Dhanaworavibul K, Hanprasertpong J, Cheewadhanaraks S et al. Bilateral pleural endometriosis. J Obstet Gynaecol Res 2006;32 86-9.
21. Dick EJ, Jr, Hubbard GB, Martin LJ et al. Record review of baboons with histologically confirmed endometriosis in a large established colony. J Med Primatol 2003;32:39-47.
22. Dinulescu DM, Ince TA, Quade BJ et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005;11:63-70.
23. Dogan E, Saygili U, Posaci C et al. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril 2004;82 (suppl. 3):1115-20.
24. Donnez J, Smoes P, Gillerot S et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686-90.
25. Drenkhahn M, Gescher DM, Wolber EM et al. Expression of angiopoietin 1 and 2 in ectopic endometrium on the chicken chorioallantoic membrane. Fertil Steril 2004;81 (suppl. 1):869-75.
26. Dunselman GA, Bouckaert PX, Evers JL. The acute-phase response in endometriosis of women. J Reprod Fertil 1998;83:803-8.
27. Eggermont J, Donnez J, Casanas-Roux F et al. Time course of pelvic endometriotic lesion revascularization in a nude mouse model. Fertil Steril 2005;84:492-9.
28. Endrich B. Asaishi K, Gotz A et al. Technical report - a new chamber technique for microvascular studies in unariesthetized hamsters. Res Exp Med (Berl) 1980;177:125-34.
29. Fedele L, Berlanda N. Emerging drugs for endometriosis. Expert Opin Emerg Drugs 2004;9:167-77.
30. Ferrero S, Ragni N, Remorgida V. Antiangiogenic therapies in endometriosis. Br J Pharmacol 2006;149:133-5.
31. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
32. Fujimoto J, Sakaguchi H, Hirose R et al. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) related to angiogenesis in ovarian endometriosis. J Clin Endocrinol Metab 1999;84:359-62.
33. Fujishita A, Hasuo A, Khan KN et al. Immunohistochemical study of angiogenic factors in endometrium and endometriosis. Gynecol Obstet Invest 1999;48 (suppl. 1.):36-44.
34. Galle PC. Clinical presentation and diagnosis of endometriosis. Obstet Gynecol Clin North Am 1989;16:29-42.
35. Giannarini G, Scott CA, Moro U et al. Cystic endometriosis of the epididymis. Urology 2006;68: 203.e1-203.e3.
36. Goteri G, Lucarini G, Filosa A et al. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril 2004;81:1528-33.
37. Groothuis PG, Nap AW, Winterhager E et al. Vascular development in endometriosis. Angiogenesis 2005;8:147-56.
38. Grümmer R. Animal models in endometriosis research. Hum Reprod Update 2006;12:641-9.
39. Grümmer R, Schwarzer F, Bainczyk K et al. Peritoneal endometriosis: Validation of an in-vivo model. Hum Reprod 2001; 16:1736-43.
40. Hajitou A, Pasqualini R, Arap W. Vascular targeting: Recent advances and therapeutic perspectives. Trends Cardiovasc Med 2006;16:80-8.
41. Halban J. Hysteroadenosis metaplastica. Wien Klin Wochenschr 1924;37:1205-6.
42. Harder Y, Amon M, Emi D et al. Evolution of ischemic tissue injury in a random pattern flap: A new mouse model using intravital microscopy. J Surg Res 2004;121:197-205.
43. Healy DL, Rogers PA, Hii L et al. Angiogenesis: A new theory for endometriosis. Hum Reprod Update 1998;4:736-40.
44. Hoffmann JN, Vollmar B, Laschke MW et al. Adverse effect of heparin on antithrombin action during endotoxemia: Microhemodynamic and cellular mechanisms. Thromb Haemost 2002;88:242-52.
45. Hoffmann JN, Vollmar B, Laschke MW et al. Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 2004;32:1011-7.
46. Hull ML, Charnock-Jones DS, Chan CL et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003;88:2889-99.
47. Hull ML, Prentice A, Wang DY et al. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod 2005;20:350-8.
48. Hur SE, Lee JY, Moon HS et al. Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis. Mol Hum Reprod 2006;12:421-6.
49. Ichida M, Gomi A, Hiranouchi N et al. A case of cerebral endometriosis causing catamenial epilepsy. Neurology 1993;43 2708-9.
50. Itoga T, Matsumoto T, Takeuchi H et al. Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis. Pathol Int 2003;53 371-5.
51. Iwabe T, Harada T, Tsudo T et al. Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998;69:924-30.
52. Kats R, Collette T, Metz CN et al. Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis. Fertil Steril 2002;78:69-76.
53. Khan KN, Masuzaki H, Fujishita A et al. Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis. Acta Obstet Gynecol Scand 2006;85:458-66.
54. Koga K, Takemura Y, Osuga Y et al. Recurrence of ovarian endometrioma after laparoscopic excision. Hum Reprod 2006;21 2171-4.
55. Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: The role of peritoneal fluid. Hum Reprod Update 1999;4:741-51.
56. Koninckx PR, Renaer M, Brosens IA. Origin of peritoneal fluid in women: an ovarian exudation product. Br J Obstet Gynaecol 1980;87 177-83.
57. Kressin P, Wolber EM, Wodrich H et al. Vascular endothelial growth factor mRNA in eutopic and ectopic endometrium. Fertil Steril 2001;76: 1220-4.
58. Laschke MW, Elitzsch A, Vollmar B et al. In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy. Fertil Steril 2005;84 (suppl. 2):1199-209.
59. Laschke MW, Elitzsch A, Scheuer C et al. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation. Br J Pharmacol 2006a;149:137-44.
60. Laschke MW, Elitzsch A, Scheuer C et al. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 2007;87:163-71.
61. Laschke MW, Elitzsch A, Vollmar B et al. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2006b;21:262-8.
62. Laschke MW, Haufel JM, Thorlacius H et al. New experimental approach to study host tissue response to surgical mesh materials in vivo. J Biomed Mater Res A 2005b;74:696-704.
63. Lebovic DI, Bentzien F, Chao VA et al. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Mol Hum Reprod 2000;6:269-75.
64. Lehr HA, Leunig M, Menger MD et al. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 1993;143:1055-62.
65. Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 2002;277 46248-55.
66. Leunig M, Yuan F, Menger MD et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res 1992;52:6553-60.
67. Maas JW, Calhaz-Jorge C, ter Riet G et al. Tumor necrosis factor-alpha but not interleukin-1 beta or interleukin-8 concentrations correlate with angiogenic activity of peritoneal fluid from patients with minimal to mild endometriosis. Fertil Steril 2001b;75 180-5.
68. Maas JW, Groothuis PG, Dunselman GA et al. Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane. Hum Reprod 2001a;16:627-31.
69. Maas JW, Le Noble FA, Dunselman GA et al. The chick embryo chorioallantoic membrane as a model to investigate the angiogenic properties of human endometrium. Gynecol Obstet Invest 1999;48 108-12.
70. Mahnke JL, Dawood MY, Huang JC. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 2000;73:166-70.
71. Matsuzaki S, Canis M, Murakami T et al. Immunohistochemical analysis of the role of angiogenic status in the vasculature of peritoneal endometriosis. Fertil Steril 2001a;76:712-6.
72. Matsuzaki S, Canis M, Darcha C et al. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 2004;82:1609-15.
73. Matsuzaki S, Murakami T, Uehara S et al. Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis. Hum Reprod 2001b;16:945-8.
74. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55.
75. McLaren J, Prentice A, Charnock-Jones DS et al. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996a; 11:220-3.
76. McLaren J, Prentice A, Charnock-Jones DS et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996b;98:482-9.
77. Menger MD, Laschke MW, Vollmar B. Viewing the microcirculation through the window: Some twenty years experience with the hamster dorsal skinfold chamber. Eur Surg Res 2002;34:83-91.
78. Meyer R. The status of adenomyosis and adenomyoma, with a discussion of seroepithelial adenomyosis and sarcomatose adeno-myometritis. Zel Gynaecol 1919;43:745-50.
79. Na YJ, Yang SH, Baek DW et al. Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes. Hum Reprod 2006;21 1846-55.
80. Nap AW, Dunselman GA, Griffioen AW et al. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertil Steril 2005;83:793-5.
81. Nap AW, Griffioen AW, Dunselman GA et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004;89:1089-95.
82. Nap AW, Groothuis PG, Demir AY et al. Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane. Hum Reprod 2003;18:30-4.
83. Nisolle M, Casanas-Roux F, Anaf V et al. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 1993;59:681-4.
84. Nisolle M, Casanas-Roux F, Donnez J. Early-stage endometriosis: Adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril 2000b;74:306-12.
85. Nisolle M, Casanas-Roux F, Marbaix E et al. Transplantation of cultured explants of human endometrium into nude mice. Hum Reprod 2000a;15:572-7.
86. Nothnick WB, D'Hooghe TM. Medical management of endometriosis: Novel targets and approaches towards the development of future treatment regimes. Gynecol Obstet Invest 2003;55: 189-98.
87. Oosterlynck DJ, Meuleman C, Sobis H et al. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril 1993;59:778-82.
88. Osuga Y, Tsutsumi O, Okagaki R et al. Hepatocyte growth factor concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1999;14:1611-3.
89. Papenfuss HD, Gross JF, Intaglietta M et al. A transparent access chamber for the rat dorsal skin fold. Microvasc Res 1979;18 311-8.
90. Patan S. Vasculogenesis and angiogenesis. Cancer Treat Res 2004; 117:3-32.
91. Piva M, Horowitz GM, Sharpe-Timms KL. Interleukin-6 differentially stimulates haptoglobin production by peritoneal and endometriotic cells in vitro: A model for endometrial-peritoneal interaction in endometriosis. J Clin Endocrinol Metab 2001;86:2553-61.
92. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992;6:886-92.
93. Ria R, Loverro G, Vacca A et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. Eur J Clin Invest 2002;32:199-206.
94. Ribatti D, Nico B, Vacca A et al. Chorioallantoic membrane capillary bed: A useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 2001;264:317-24.
95. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
96. Russell WW. Aberrant portions of the müllerian duct found in an ovary. Ovarian cysts of müllerian origin. Bull. John Hopkins Hospi. 1899;10:8-10.
97. Ryan JP, Tseng JF, Schriock ED et al. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995;63:929-32.
98. Sampson JA, Peritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-69.
99. Schweppe K. Histological and electron-microscopy studies on endometriosis. Horm Res 1989;32 (suppl. 1):106-9.
100. Sharkey AM, Day K, McPherson A et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab 2000;85:402-9.
101. Shifren JL, Tseng JF, Zaloudek CJ et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-8.
102. Shimizu I, Nakanishi R, Yoshino I el al. An endometrial nodule in the lung without pelvic endometriosis. J Cardiovasc Surg (Torino) 1998;39:867-8.
103. Story L, Kennedy S. Animal studies in endometriosis: A review. ILAR J 2004;45:132-8.
104. Suzumori N, Zhao XX, Suzumori K. Elevated angiogenin levels in the peritoneal fluid of women with endometriosis correlate with the extent of the disorder. Fertil Steril 2004;82:93-6.
105. Szamatowicz J, Laudanski P, Tomaszewska I et al. Chemokine growth-regulated-alpha: A possible role in the pathogenesis of endometriosis. Gynecol Endocrinol 2002;16:137-41.
106. Takemura Y, Osuga Y, Harada M et al. Concentration of adiponectin in peritoneal fluid is decreased in women with endometriosis. Am J Reprod Immunol 2005;54:217-21.
107. Takehara M, Ueda M, Yamashita Y et al. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 2004;,35:1369-75.
108. Tan XJ, Lang JH, Liu DY et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 2002;78:148-53.
109. The Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility. Fertil Steril 2004;81 1441-6.
110. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 1985;44:684-94.
111. Von Recklinghausen F. Adenomyomas and cystadenomas of the wall of the uterus and tube: Their origin as remnants of the wolffian body. Wien Klin Wochenschr 1896;8:530.
112. Wolber EM, Kressin P, Meyhofer-Malik A et al. Differential induction of matrix metalloproteinase 1 and 2 in ectopic endometrium. Reprod Biomed Online 2003;6:238-43.
113. Yang Y, Degranpre P, Kharfi A et al. Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J Clin Endocrinol Metab 2000;85:4721-7.
114. Yoshino O, Osuga Y, Koga K et al. Concentrations of interferongamma-induced protein-10 (IP-10), an antiangiogenic substance, are decreased in peritoneal fluid of women with advanced endometriosis. Am J Reprod Immunol 2003;50:60-5.
115. Zamah NM, Dodson MG, Stephens LC et al. Transplantation of normal and ectopic human endometrial tissue into athymic nude mice. Am J Obstet Gynecol 1984;149:591-7.